Crescita Therapeutics (TSE:CTX) Shares Up 1.8% – Here’s What Happened

Crescita Therapeutics Inc. (TSE:CTX) shares rose 1.8% on Monday . The stock traded as high as C$0.58 and last traded at C$0.58. Approximately 3,525 shares traded hands during mid-day trading, a decline of 40% from the average daily volume of 5,882 shares. The stock had previously closed at C$0.57.

Crescita Therapeutics Stock Up 1.8 %

The company has a debt-to-equity ratio of 6.02, a quick ratio of 2.29 and a current ratio of 3.37. The firm has a market capitalization of C$11.24 million, a P/E ratio of -3.87 and a beta of 1.69. The stock has a fifty day moving average price of C$0.58 and a two-hundred day moving average price of C$0.59.

Insiders Place Their Bets

In related news, Director Jose Darocha acquired 86,000 shares of Crescita Therapeutics stock in a transaction that occurred on Friday, December 27th. The stock was acquired at an average price of C$0.60 per share, for a total transaction of C$51,436.60. 10.87% of the stock is owned by corporate insiders.

About Crescita Therapeutics

Crescita Therapeutics Inc, a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel for the development of topicals containing cannabis and hemp.